ZA929945B - Method of diagnosing combined cognitive/debilatory disorders. - Google Patents

Method of diagnosing combined cognitive/debilatory disorders.

Info

Publication number
ZA929945B
ZA929945B ZA929945A ZA929945A ZA929945B ZA 929945 B ZA929945 B ZA 929945B ZA 929945 A ZA929945 A ZA 929945A ZA 929945 A ZA929945 A ZA 929945A ZA 929945 B ZA929945 B ZA 929945B
Authority
ZA
South Africa
Prior art keywords
debilatory
diagnosing
disorders
combined cognitive
cognitive
Prior art date
Application number
ZA929945A
Inventor
William Carter
Original Assignee
Hem Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Pharma Corp filed Critical Hem Pharma Corp
Publication of ZA929945B publication Critical patent/ZA929945B/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA929945A 1991-12-23 1992-12-22 Method of diagnosing combined cognitive/debilatory disorders. ZA929945B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81143291A 1991-12-23 1991-12-23

Publications (1)

Publication Number Publication Date
ZA929945B true ZA929945B (en) 1993-08-02

Family

ID=25206543

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA929945A ZA929945B (en) 1991-12-23 1992-12-22 Method of diagnosing combined cognitive/debilatory disorders.

Country Status (4)

Country Link
CN (1) CN1074537A (en)
AU (1) AU3419793A (en)
WO (1) WO1993013419A1 (en)
ZA (1) ZA929945B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003509452A (en) * 1999-09-24 2003-03-11 スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム Adjuvant containing polyoxyethylene alkyl ether or ester and at least one nonionic surfactant
DE10306089B4 (en) * 2002-02-09 2006-01-19 Bieger, Wilfried P., Priv.-Doz. Dr.med.habil. Procedures and test kits for the determination of neuroimmunological disorders
DE202010004193U1 (en) 2010-03-22 2011-05-05 Bieger, Wilfried P., Priv.-Doz. Dr.med.habil. Test kits for the determination of neuroregulatory and mental disorders
DE102011005878A1 (en) 2010-03-22 2011-12-01 Wilfried P. Bieger Determining neuromodulatory or mental disorders using arrangements for liquid chromatography, comprises measuring concentrations of neurotransmitters in blood cells and carrying out concentration measurements in thrombocytes

Also Published As

Publication number Publication date
AU3419793A (en) 1993-07-28
CN1074537A (en) 1993-07-21
WO1993013419A1 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
AU3602693A (en) Diagnosing brain conditions by quantitative electroencephalography
EP0617918A3 (en) Analysis of potential course signals of an electrocardiogram.
EP0222913A4 (en) Image diagnosing apparatus.
GR1002052B (en) Alimentary influence agent of the nerves coming from the brain
SG89228A1 (en) Process for the ctalytic partial oxidation of hydrocarbons
PL295811A2 (en) Method of obtaining 1,2-dihydro-2-ketopyridines
EP0791177A4 (en) Method for diagnosis of thrombotic disorders
EP0582462A3 (en) Ultrasonic diagnosing apparatus.
ZA929945B (en) Method of diagnosing combined cognitive/debilatory disorders.
EP0669361A3 (en) Method for the preparation of polyheterosiloxanes.
ZA93164B (en) Method of diagnosing combined cognitive debilatory disorders.
EP0608745A3 (en) Method of producing MOS devices.
PL327141A1 (en) Method of obtaining 9,11 beta-epoxysteroides
GB9316369D0 (en) Diagnostic method
PL297518A1 (en) Method of obtaining 4,6-dialkoxypyrimidines
IL107515A (en) Diagnosis of mental disorders
EP0602653A3 (en) Asymmetric hydrogenation of dihydrofuroimidazole derivatives.
PL295760A1 (en) Method of obtaining 4,4'-diamine benzene sulfonanilide
GB9223988D0 (en) Diagnosis of eye disorders
PL294887A1 (en) Method of obtaining n 1, n 5, n 10, n 14 - tetrakis/ 2,3-dihydroxy-4-carboxybenzoyl/ tetraazateradecane
DE4495155T1 (en) Diagnosis method
ZA95511B (en) Treatment of anorectal disorders
GB9325723D0 (en) Measurement of the cardioinhibitory activity of the brain
GB9412984D0 (en) Methods of diagnosis
PL303650A1 (en) Method of obtaining 1,2,3,4,10,14b-hexahydro-2-methylodibenzo(c,f)-pyrasino-(1,2-a)-azepin